Article

Bausch + Lomb supports pediatric outreach event

Boston Foundation for Sight (BFS) has received a $15,000 charitable donation from Bausch + Lomb (B + L) to support Stevens-Johnson Syndrome (SJS) Kids Week 2012.

Needham, MA-Boston Foundation for Sight (BFS) has received a $15,000 charitable donation from Bausch + Lomb (B + L) to support Stevens-Johnson Syndrome (SJS) Kids Week 2012.

SJS Kids Week is an annual outreach event for pediatric SJS survivors and their families. The founder of SJS Kids Week, Lynette Johns, OD, envisioned a special week where families from all over the world could live together and receive emotional support and sight-saving treatment.

“We are so thrilled with this generous charitable donation,” said Dr. Johns. “This is the latest in a long history of financial support from B + L, and we are very grateful that they have chosen to sponsor SJS Kids Week again this year.”

An intense immune reaction to medications or infections, SJS can cause severe burn-like lesions on the skin, organs, and mucous membranes, including the eyes.

BFS is a nonprofit eye health-care organization with a mission to improve the quality of life for patients and their families by transforming the understanding, treatment, and care of complex corneal disease. For more information, visit www.bostonsight.org.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.